Want to join the conversation?
$BIIB said that it launched BENEPALI, biosimilar version of Enbrel, in 1Q16 in six European countries. The company said that FLIXABI, biosimilar version of Remicade, received a positive opinion from Committee for Medicinal Products for Human Use, and is waiting approval from European Commission.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.